Yuval Boger interviews Helmut Katzgraber, general partner at 55North and former quantum leader at AWS. They discuss Helmut’s view that the most promising near- to mid-term quantum applications are in quantum simulation for materials, chemicals, and pharma, rather than optimization. They also explore European competitiveness, venture opportunities across the quantum stack, cloud and on-prem deployment [...] The post Podcast with Helmut Katzgraber, General partner at 55North appeared first on Quantum Computing Report .
The increased maturity and investor interest in quantum computing are prompting discussions about the most viable near-term applications and deployment strategies.
This interview highlights a convergence of expert opinion on the most promising immediate applications for quantum technology, crucial for investment and R&D prioritization.
The focus for quantum computing is shifting more strongly towards quantum simulation for materials, chemicals, and pharma, away from a broad 'optimization' category in the near-to-mid term.
- · Quantum simulation developers
- · Materials science
- · Pharmaceutical industry
- · European quantum tech
- · Overly broad quantum optimization ventures
Increased investment and research in quantum simulation for materials and drug discovery.
Accelerated development of new materials and pharmaceutical compounds due to enhanced simulation capabilities.
Emergence of specialized quantum software and services companies targeting these specific vertical markets, potentially leading to new industry standards for quantum materials design.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at Quantum Computing Report